Latest Sense Stories
CARLSBAD, Calif., Jan. 6, 2011 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at J.P. Morgan's 29th Annual Healthcare Conference on Thursday, January 13, 2011 at 8:00 a.m.
CARLSBAD, Calif., Jan. 4, 2011 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announces the following webcast: What: Recent Advances in Isis' Development Pipeline Thursday, January 06, 2011 at 12:00 p.m. ET /9:00 When: a.m.
HOERSHOLM, Denmark and SAN DIEGO, Jan. 4, 2011 /PRNewswire/ -- Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the research and development of mRNA and microRNA targeted therapies, and Pfizer Inc.
The performance of a brain-machine interface designed to help paralyzed subjects move objects with their thoughts is improved with the addition of a robotic arm providing sensory feedback.
Monkeys moved thought-controlled computer cursors more quickly and accurately when provided with additional sensory feedback.
CARLSBAD, Calif., Dec. 1, 2010 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc.
In a study in the Proceedings of the National Academy of Sciences journal, USC College's Emily Liman reveals what is behind all the puckering -- how people perceive sour flavors.
CARLSBAD, Calif., Nov. 23, 2010 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc.
New research indicates that the integration of senses and functions in the brain is common.
CARLSBAD, Calif. and VANCOUVER, Canada, Nov. 16, 2010 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) and Xenon Pharmaceuticals Inc.
More Images (2 images) »